The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice

The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice

Objective: The development of glucagon-like peptide-1 receptor (GLP-1R) agonists for the treatment of type 2 diabetes and obesity has been accompanied by evidence for anti-inflammatory and cytoprotective actions in the heart, blood vessels, kidney, and brain. Whether GLP-1R agonists might be useful...

Full description

Saved in:
Bibliographic Details
Main Authors: Leticia Forny Germano (Author), Jacqueline A. Koehler (Author), Laurie L. Baggio (Author), Fiona Cui (Author), Chi Kin Wong (Author), Nikolaj Rittig (Author), Xiemin Cao (Author), Dianne Matthews (Author), Daniel J. Drucker (Author)
Format: Book
Published: Elsevier, 2024-11-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items